Hepatitis A virus (HAV) is a single-stranded, positive-sense RNA virus and a hepatotropic member of the Picornaviridae. Despite successes in vaccine development, HAV remains a common cause of enterically transmitted hepatitis globally, responsible for epidemics in developing and developed countries with symptoms ranging from mild inflammation and jaundice to acute liver failure 1,2 . A comprehensive picture of the cellular factors, which are co-opted by HAV to replicate and establish successful infection, is missing. Here, using a genome-scale CRISPR screen in a human hepatocyte cell line, we identified genes involved in sialic acid and ganglioside biosynthesis, the eukaryotic initiation factor complex and the endosomal sorting complexes required for transport (ESCRT), which have known roles in viral pathogenesis 3-12 . Additionally, we uncovered host factors not previously linked to HAV infection. We found all components of the cellular machinery for UFMylation, a ubiquitin-like protein modification 13 , and showed that optimal translation of the HAV genome depends on functional UFM1 conjugation in host cells. Furthermore, we identified PAPD5, PAPD7 and ZCCHC14, which form a complex related to the yeast Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) complex 14 . We demonstrated that loss of the TRAMP-like complex directly results in reduced viral translation efficiency, without affecting HAV poly(A) tails. Finally, we showed that pharmacological inhibition of PAPD5 and PAPD7 decreased HAV replication in hepatocyte cells as well as human liver organoids. Thus, our study revealed novel cellular pathways, specifically important for HAV translation, and provided a new strategy for host-directed therapy of severe HAV infection.
unbiased fashion, which provides insights into the molecular host-pathogen interactions and may reveal suitable targets for host-directed therapies 16 .
To identify host cellular factors that are critical for HAV infection, we conducted a genome-wide CRISPR knockout (KO) screen in the human hepatocyte cell line Huh7.5.1 using the cytopathic HAV HM175/18f strain (Fig. 1a ). Infection led to notable cell death after ~3 days and surviving cells were collected after 12 days for analysis. We consistently found enrichment of guide RNA (gRNA) sequences targeting genes involved in several pathways known to be required for picornaviral replication (Fig. 1b, Supplementary Fig. 1a , Supplementary Table 1 ). For example, sialic acid and ganglioside biosynthesis (GNE, CMAS, SLC35A1, UGCG, ST3GAL5), which were previously implicated in entry of picorna-and other viruses [3] [4] [5] [6] . We also identified PTBP1 and members of the eukaryotic initiation factor complex (EIF4B, EIF3C, EIF3CL), which have known roles in IRES-mediated translation of HAV and other picornaviruses [7] [8] [9] [10] . VPS4A is an ESCRT component, important for budding of several enveloped viruses as well as egress of HAV 11, 12 . Identification of these genes known to be important for HAV or viral pathogenesis in general highlights the robustness of this genetic screen. Importantly, gene ontology (GO) analysis of enriched genes (RIGER p-value < 0.001) revealed additional pathways, which have not previously been implicated in HAV infection, such as the machinery for UFMylation (UFM1, UBA5, UFL1, UFC1, UFSP2), a ubiquitin-like protein modification 17 , and the TRAMP complex components PAPD5 (also known as TENT4B or TRF4-2) and PAPD7 (also known as TENT4A or TRF4-1) (Fig. 1b,c and Supplementary Table 2) 18 . Zinc Finger CCHC Domain-Containing Protein 14 (ZCCHC14), which has been shown to associate with PAPD7 using BioID, is likely to be part of a TRAMP-like complex, which generally contains a zinc knuckle protein 19, 20 .
We systematically compared our hits with CRISPR screens for host factors of human rhinovirus C15 (HRV-C15) and enterovirus D68 (EV-D68), two other Picornaviridae members 21 . Other than sialic acid biosynthesis genes among the EV-D68 hits, there were no commonalities, indicating divergent evolution of host factor dependence between HAV and these distantly related picornaviruses ( Supplementary Fig. 1b,c) . Additionally, we compared our results to a CRISPR screen for hepatitis C virus (HCV) infection, another hepatotropic positive-sense RNA virus (and member of the Flaviviridae family) but found no overlap in the host factor requirements ( Supplementary Fig. 1d) 22 .
To validate the results of our screen, we generated isogenic KO cell lines in several genes using CRISPR-Cas9 gene editing ( Supplementary Fig. 2a ). Upon HAV infection, we observed significant reduction of viral RNA (ranging from 10-1,000 fold) relative to levels in wild-type (WT) cells at 72 hours post-infection (hpi) (Fig. 1d ). As PAPD5 and PAPD7 are both human orthologues of yeast Trf4p and display redundancy in their polyadenylation function 18 , we generated PAPD5/PAPD7 double knockout (DKO) cell lines ( Supplementary Fig. 2b ). We observed a significantly stronger reduction in viral replication in the DKO cells compared to the single PAPD5 or PAPD7 KO cells underscoring their redundant activity for HAV replication (Fig. 1e ). Next, we performed a timecourse infection assay using a recombinant reporter virus that expresses nanoluciferase from within its polyprotein (HAV-NLuc). We measured a ~10 4 fold increase in luminescence in WT cells after 72hpi but there was striking attenuation of luciferase expression in host factor KO lines (Fig. 1f ). Moreover, when we complemented UBA5, PAPD5 and ZCCHC14 KO cells with the respective cDNAs, we observed a significant increase in HAV RNA levels ( Fig. 1g i). To rule out that phenotypes are not only observed with the highly tissue culture adapted HM175/18f strain, we additionally performed infection assays in KO cell lines using a low-passage HM175 strain with similar results ( Supplementary Fig. 3 ).
Next, we compared replication of different Picornaviridae members in UFM1 KO cells ( Supplementary Fig. 2c ). As expected, HAV RNA levels were greatly reduced while enterovirus 71 (EV-71) and encephalomyocarditis virus (EMCV) RNA levels were not affected ( Fig. 1j ). Interestingly, human rhinovirus A2 (RV-A2) replication was significantly increased suggesting that UFMylation can mediate pro-and antiviral functions in host cells, depending on the virus species. In cells deficient in both PAPD5 and PAPD7, HAV RNA levels were severely and EMCV RNA levels moderately decreased while EV-71 and RV-A2 replication was unaffected ( Fig. 1k ).
It is of note that our screen did not reveal HAVCR1 (also known as TIM1) as an essential host factor for HAV infection. HAVCR1 was originally identified as a HAV receptor but a more recent study questioned its essentiality for HAV infection 23, 24 . To address this further, we generated isogenic HAVCR1 KO lines and performed a viral attachment and internalization assay ( Supplementary Fig. 4 ). We only observed a minor defect of internalized virions at 6hpi and viral RNA levels were only reduced by ~2 fold relative to WT cells at 30hpi ( Supplementary Fig. 4 ). Thus, HAVCR1 KO cells were unlikely to be protected against cytopathic HAV infection in the CRISPR screen. By contrast, in SLC35A1 KO cells intracellular viral RNA was decreased by ~80% at 6hpi and ~95% at 30hpi ( Supplementary Fig. 4 ). We conclude that HAVCR1 is not essential for the HAV life cycle, while sialic acid biosynthesis is critical for viral entry and establishing infection. Together, these data confirm that the genes identified by the CRISPR screen play an important role in the HAV life cycle.
UFM1 encodes the 85 amino acid long ubiquitin-fold modifier 1, which acts as a protein modification and is conserved among most eukaryotes except for yeast and other fungi 13 . Like ubiquitination, UFM1 is covalently attached to its targets following an E1-E2-E3 reaction consisting of the UFM1-activating enzyme UBA5, the UFM1-conjugating enzyme UFC1 and the UFM1-specific ligase UFL1 ( Fig. 2a) 13, 25 . Usually, UFM1 is present in a precursor form, which first requires cleavage of the last two C-terminal amino acids by the UFM1-specific protease UFSP2 to expose Gly at position 83 (ref. 13 ). UFSP2 also operates as the major de-UFMylation enzyme, removing UFM1 molecules from their targets 26 . Our screen identified all known components of the UFMylation machinery including the additionally associated proteins DDRGK1 and ODR4 (encoded by C1orf27) ( Fig. 2a , Supplementary Table 1) 27, 28 . To date, this protein modification has not been implicated to play a role in viral infections. WT cells contain free UFM1 as well as conjugated UFM1 as detected by immunoblot ( Fig. 2b ). To probe whether functional conjugation of UFM1 is required for HAV infection, we mutated different components of the pathway. Deletion of UBA5 led to an absence of conjugated UFM1, while UFSP2 KO resulted in hyperconjugation ( Fig. 2b ). However, both conditions led to a stark reduction of viral RNA in infected cells ( Fig. 2c ). Moreover, we generated cell lines either lacking UFM1 completely or expressing WT UFM1, Gly83Ala UFM1 or ∆C3 UFM1 (lacking the last 3 C-terminal amino acids) and showed the presence of conjugated UFM1 in cells containing WT UFM1, hyper-conjugation with Gly83Ala UFM1 and absence of UFM1 linkage for ∆C3 UFM1 consistent with previous findings (Fig. 2b) 13 . Complementation with WT UFM1 significantly restored HAV replication, although less than the hyper-conjugated Gly83Ala UFM1, possibly because the Gly83Ala mutant may be more stable due to resistance to UFM1 processing ( Fig. 2c ). By contrast, conjugation-deficient ∆C3 UFM1 did not rescue viral infection indicating that functional UFM1 conjugation is indeed critical for HAV ( Fig. 2c ). Complementation of UBA5 KO cells with WT UBA5 but not catalytically inactive enzyme also restored UFM1 conjugation and viral replication ( Fig. 2b , Supplementary Fig. 5a ,b).
Next, we used HAV replicon RNA expressing firefly luciferase to assess whether the defect occurs during the viral translation or genome replication step and detected a moderate defect in UBA5 and UFM1 KO cells within 10h post-electroporation, which further increased at later timepoints ( Fig. 2d ). To specifically measure the effect on translation of incoming viral RNA, we additionally used a replication-incompetent replicon (containing a GDDàGAA mutation in the viral polymerase) and observed a greater than 2-fold decrease of luciferase expression in both UBA5 and UFM1 KO cells ( Fig. 2e ). Thus, we conclude that functional conjugation of UFM1 is required for efficient translation of HAV RNA.
PAPD5 and PAPD7 are two non-canonical poly(A) RNA polymerases (ncPAPs), which can transfer oligo(A) to a variety of RNA substrates (including mRNAs, miRNAs, snoRNAs and rRNAs) in a template-independent manner [29] [30] [31] [32] [33] . Their activities have been shown to stabilize mRNAs for translation as well as to specify different RNA species for turnover by the exosome complex 14, 18, 34 . ZCCHC14 has been implicated to interact with these ncPAPs forming a TRAMP-like complex 19, 35 . We measured the effects of either PAPD5/7 DKO or ZCCHC14 KO on viral translation and replication using viral replicon RNA and observed a notable defect early post-electroporation before the onset of viral genome replication ( Fig. 3a ). While we detected low levels of replication between 24 and 32h in the host factor KO cell lines, luminescence dropped to near background levels by 48h. We determined that the catalytic activities of PAPD5 and PAPD7 are likely to be required to support viral infection as complementation of KO or DKO cells with WT PAPD5 or PAPD7 but not catalytically inactive (CAT) PAPD5 or PAPD7 (containing two aspartate to alanine substitutions in the active site) restored HAV replication ( Supplementary Fig. 6a -c) 29 . PAPD5 and PAPD7 can regulate the length of poly(A) tails of certain mRNAs, which can affect RNA stability and translation. As HAV has a polyadenylated genome, we assessed the length of viral poly(A) tails from infected WT and DKO cells by polyacrylamide gel electrophoresis but we did not observe a difference (Fig. 3b ). We additionally analyzed the poly(A) tails by TOPO cloning and Sanger sequencing with similar results (Fig. 3c ). Recently, it was shown that PAPD5 and PAPD7 can introduce guanosines at low frequencies into poly(A) tails resulting in increased stability against CCR4-NOT dependent deadenylation and prolonged mRNA half lives 36 . However, we did not observe an elevated frequency of non-adenosine nucleotides in WT vs DKO cells within HAV poly(A) tails ( Fig. 3e , Supplementary Table 3 ). Rather, almost all tails exclusively consisted of adenosines. In addition to the absence of changes in HAV poly(A) tail length or composition, we did not detect differences in overall viral RNA stability between WT, DKO as well as ZCCHC14 KO cells early post viral entry (2-8h), suggesting that HAV RNA is fairly stable even in absence of TRAMP components ( Fig. 3e ). Finally, we probed viral translation directly using the replicationincompetent HAV replicon and observed drastically reduced luciferase levels in the first 10h postelectroporation in DKO and ZCCHC14 KO cells, consistent with the WT replicon data ( Fig. 3f ). By contrast, translation of electroporated firefly mRNA was not affected ( Supplementary Fig. 7a ). Additionally, we ruled out effects on the poly(A) tails of in-vitro transcribed and electroporated replicon RNA containing a defined stretch of 40 adenosines ( Supplementary Fig. 7b ). Therefore, we propose a critical role of the TRAMP-like complex in facilitating HAV translation in a poly(A) tail length and stability-independent manner.
Next, we sought to explore whether pharmacological inhibition of PAPD5/7 exhibits an antiviral effect on HAV replication. We used RG7834 (Fig. 4a ), a small molecule compound belonging to the chemical class of the dihydroquinolizinones, which was first identified as a potent inhibitor for hepatitis B virus (HBV) surface antigen (HBsAg) secretion 37 . Additional studies using yeast three-hybrid screening identified PAPD5 and PAPD7 as the cellular targets for RG7834 38 . We performed a dose-response curve and calculated a 50% effective concentration (EC50) of 12.76nM for inhibition of HAV replication, which is far below the reported 50% cytotoxic concentration (CC50) of >10 µM and consistent with our measurements ( Fig. 4b , Supplementary  Fig. 8a ) 37 . Drug treatment of infected PAPD5 or PAPD7 KO cells suggested that RG7834 has a stronger inhibitory effect on the PAPD5 activity as reduction of viral RNA is more substantial in the PAPD7 KO+RG7834 condition ( Supplementary Fig. 8b ). Intrigued by the fact that RG7834 inhibits both HAV and HBV, we also measured the effects on two additional liver-specific viruses, HCV and hepatitis E virus (HEV). However, RG7834 only showed significant reduction of HAV and HBV RNA levels ( Fig. 4c-f ). This is consistent with unchanged viral replication levels of HCV and HEV in DKO cells ( Supplementary Fig. 8c ). Finally, we performed infection assays in human liver organoid cultures 39 . Both stem cell-like and differentiated organoids were infected with HAV and treated with 100nM RG7834. In both organoid conditions, we observed significant reduction of HAV RNA (Fig. 4g ,h), highlighting that pharmacological targeting of PAPD5/7 is a promising strategy for host-directed therapy of HAV infection.
Discussion
This study provides a comprehensive assessment of the host factors that are required for HAV infection. We reveal two cellular pathways, UFMylation and a TRAMP-like complex, which had not been implicated in HAV replication before. We demonstrated that UFMylation is required for HAV translation in a UFM1-conjugation dependent manner. The cellular function of this protein modification is still an emerging field of research. Recently, the Ribosomal Protein L26 (RPL26) was identified as a major target for UFMylation in human cells and linked to a role in ER-localized ribosome-associated quality control 40, 41 . Specific ribosomal or ribosome-associated proteins have been shown to be required for efficient IRES-mediated translation of viral genomes but whether HAV translation depends on ribosomes containing ufmylated RPL26 warrants further investigation 42, 43 . In general, UFMylation has been linked to the regulation of ER stress response and autophagy and it is possible that HAV is vulnerable to perturbations of the cellular protein homeostasis 17 . Interestingly, our results indicate that both hypo-and hyperconjugation of UFM1 is suboptimal for HAV infection. By contrast, we found that deletion of UFM1 led to a substantial increase of RV-A2 infection, suggesting that UFMylation can also mediate antiviral functions in host cells. Thus, the contrasting phenotypes of HAV and RV-A2 replication in response to UFM1 KO can be utilized as molecular tools for future studies of the effects of UFMylation on viral pathogenesis as well as cellular processes in general.
Furthermore, we identified ZCCHC14 together with PAPD5 and PAPD7, two ncPAPs, which have been shown to be the catalytic subunit of a TRAMP-like complex involved in posttranscriptional quality control mechanism 14 . In context of the nuclear TRAMP machinery, PAPD5/7 interact with ZCCHC7, another CCHC-motif containing zinc knuckle protein, and the Mtr4 exosome RNA helicase (MTREX/SKIV2L2), which were both not enriched in the HAV CRISPR screen. This suggests that PAPD5/7 can form different complexes with specific cellular activities, for example template-independent polyadenylation of its nuclear RNA substrates with short oligo(A) tails for targeted degradation by the exosome or increase of mRNA stability by poly(A) tail extension or mixed tailing 18, 44 . We demonstrated that the pro-viral function of the identified TRAMP-like complex is important for the translatability of HAV RNA, independent from modifying its poly(A) tails. This is consistent with previous observations that picornavirus polyadenylation is template-dependent, for example by the presence of a homotypic poly(U) sequence in the picornavirus negative-sense RNA 45 . Moreover, studies using poliovirus, another picornavirus, suggested that the picornaviral RNA-dependent RNA polymerase use reiterative transcription as it replicates the poly(A) tails of viral RNA 46, 47 . These findings support that ncPAPs are not required for HAV poly(A) tail generation or maintenance. In studies using C. elegans, deletion of the worm orthologs of PAPD5 (gld-4) and ZCCHC14 (gls-1) led to reduced polysome formation but did not affect global poly(A) tail lengths providing evidence of polyadenylation-independent functions of TRAMP-like complexes 48 . The utilization and re-purposing of cellular RNA-binding proteins to enhance translation or other steps in the viral life cycle is a commonly used strategy by positivesense RNA viruses 49, 50 . Unexpectedly, we found that mutations in the active sites of PAPD5/7 affected HAV infection. It is possible that the catalytic mutations have structural implications and impair the co-opted non-catalytic activity (as suggested by reduced protein levels of the catalytic mutant by immunoblot). Alternatively, PAPD5 and PAPD7 may affect stable expression or turnover of another host factor critical to HAV translation through RNA tailing.
Interestingly, other tested picornaviruses were not dependent on the TRAMP-like complex for efficient translation despite commonalities in their gene expression strategy. Surprisingly though, PAPD5, PAPD7 and ZCCHC14 were identified as critical factors for HBV infection in chemical and CRISPR screens 35, 38 . HBV is a chronic, hepatotropic DNA virus, which replicates through reverse transcription, uses host RNA polymerase II for the transcription of viral mRNAs and initiates translation independent of an IRES 51, 52 . Mechanistically, it was shown that the TRAMP-like complex played an important role in HBsAg expression by poly(A) tail extension of HBsAg mRNAs 35 . Together, this highlights a remarkable convergence of two unrelated hepatitis viruses to co-opt the same cellular complex through different molecular functions.
Finally, we provided proof-of-concept that pharmacological inhibition of PAPD5/7 decreases HAV (as well as HBV) levels. Fulminant hepatitis is a rare but severe complication of HAV infection, which can result in liver transplantation or death. As current treatment is largely supportive, inhibition of PAPD5/7 may thus be a new strategy for host-directed therapy in cases of fulminant hepatitis. Overall, this study provides a comprehensive picture of HAV host factors. In addition to the eukaryotic initiation factor complex and PTBP1 known to be required for HAV translation, we uncovered UFMylation and the TRAMP-like complex, thus highlighting a complex interplay of HAV with its host cell to achieve successful viral protein biogenesis. 
Methods
Cell lines, viruses and reagents Huh7.5.1 (gift from Frank Chisari) and HEK293FT (Thermo Scientific) were cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS, Omega Scientific), penicillin/streptomycin (Gibco), non-essential amino acids (Gibco) and L-glutamine (Gibco) at 37C and 5% CO2. HepG2-NTCP-K7 cells 53 (gift from Ulrike Protzer) and HepAD38 cells 54 (gift from Christoph Seeger) were cultured in DMEM/F12 (Gibco) supplemented with 10% FBS, penicillin/streptomycin, non-essential amino acids, L-glutamine and sodium pyruvate (Gibco) at 37C and 5% CO2. Cell lines were tested negative for mycoplasma and were authenticated by STR profiling. Hepatitis A virus HM175/18f (NR-137) was obtained through BEI Resources (NIAID, NIH) and HM175/clone 1 (VR-1541) through ATCC. HAV strains were propagated in Huh7.5.1 cells grown in adeno expression media (Gibco) supplemented with penicillin/streptomycin, nonessential amino acids and L-glutamine, supernatant was collected 5-12 dpi and filtered (0.45 micron). To generate concentrated HAV stocks, supernatant was incubated with 8% PEG-8000 at 4C overnight, centrifuged at 3,200g for 60min and pellet was resuspended in a small volume of DMEM with 10% FBS and aliquoted. For the generation of HAV-Nluc (gift from Stanley Lemon) 55 , the infectious clone plasmid was linearized, RNA was in-vitro transcribed using MEGAscript T7 Transcription Kit (Invitrogen) and transfected into Huh7.5.1 cells using TransIT-LT1 Transfection Reagent (Mirus Bio). Subsequently, cell supernatant was collected 8-13dpi, filtered and aliquoted. Purified encephalomyocarditis virus (NR-46441) was obtained through BEI Resources (NIAID, NIH). Enterovirus 71 (MP4), rhinovirus A2 and HCV JFH1 stocks were kindly provided by Jan Carette. For HBV production, supernatant was collected from HepAD38 cells, filtered (0.45 micron), and concentrated using 8% PEG-8000 as described above. The HEV infectious clone (genotype 3) was obtained from the NIH/NIAID and viral RNA was generated by in-vitro transcription from linearized plasmid 56 . For virus stocks, titers were determined by plaque-or focus-forming assay. RG7834 was purchased from MedKoo Biosciences and resuspended in DMSO at 50mg/ml. Puromycin and blasticidin were obtained from Gibco. CRISPR host factor screen Huh7.5.1 cells were stably transduced with lentivirus from lentiCas9-Blast (Addgene #52962, gift from Feng Zhang) and subsequently selected using blasticidin. Next, a total of 300 million Huh7.5.1-Cas9 cells were then transduced with lentivirus containing the human GeCKO v2 library (Addgene #1000000049, gift from Feng Zhang) at a multiplicity of infection (MOI) of 0.3, subsequently selected using puromycin and expanded for 10 days. A total of 60 million mutagenized cells for each sublibrary (A and B) were collected for genomic DNA extraction, and a total of 45 million mutagenized cells for each sublibrary were infected with 15ml of unconcentrated HAV HM175/18f per T175 flask (1:1 diluted with fresh DMEM media). An additional 15ml of media was added after 2h. Media was refreshed 4 and 8dpi and surviving cells were collected 12dpi for genomic DNA extraction using QIAamp DNA Blood Maxi Kit (Qiagen). gRNA encoding DNA sequences were amplified in a two-step nested PCR using KAPA HiFi HotStart ReadyMixPCR Kit (Kapa Biosystems) and sequenced on an Illumina NextSeq (High Output) (for primer sequences, see Supplementary Table 4 ). For analysis, reads were aligned to gRNA reference table, enrichment of each gRNA was calculated by comparing the relative abundance in the selected and unselected cell population and gene significance was calculated using RIGER (using weighted sum) or MaGeCK 57, 58 . Gene ontology analysis of enriched genes in target list (RIGER p-value < 0.001) was performed using GOrilla 59 .
Generation of clonal KO cell lines
Oligos containing gRNA sequence were annealed and ligated into pX458 (Addgene #48138, gift from Feng Zhang). Cells were transfected with pX458 constructs using Lipofectamine 3000 (Invitrogen) and two days later GFP positive cells were single-cell sorted into 96-well plates using a Sony SH800 cell sorter. For genotyping, genomic DNA was isolated from obtained clones using QuickExtract (Lucigen), the gRNA-targeted sites PCR amplified and the products Sangersequenced. Obtained sequences were compared to reference sequences for indel mutations or large deletion. A list of all used sgRNA oligo and genotyping primer sequences can be found in Supplementary Table 4 .
RT-qPCR assays Cells were plated in 96-well plates (in triplicates for each condition) and infected the next day with virus at the following MOIs: HAV (~5-50 FFU/cell), RV-A2 (~1 PFU/cell), EV-71 (~0.2 PFU/cell), EMCV (~0.2 PFU/cell), HCV (~1 FFU/cell) and HBV (~1 FFU/cell). Cells were harvested, lysates reverse transcribed and quantitative PCR performed on a Bio-Rad CFX96 Touch system using the Power SYBR Cells-to-CT kit (Invitrogen). All viral RNA levels were normalized to 18S levels. Primer sequences can be found in Supplementary Table 4 .
Viral attachment and entry assay 96-well plates containing WT, SLC35A1 KO or HAVCR1 KO Huh7.5.1 cells were chilled on ice before infection with HAV HM175/18f at an MOI of 500 FFU/cell. Cells were incubated for 1h on ice before moving them to a 37C incubator. At each harvest timepoint, cells were washed three times with PBS and processed for RT-qPCR as described above.
HAV nanoluciferase reporter assay Cells were plated in 96-well plates and infected the next day with equal amounts of HAV-Nluc. Lysates were harvested by washing once with PBS wash followed by addition of 22µl of Passive Lysis Buffer (Promega) under shaking for 15min. For luminescence readout, 15µl of lysate were mixed with 50µl of Nano-Glo assay buffer (Promega) in a flat bottom white-walled luminescence plate, incubated for 5min at room temperature and read on an EnVision plate reader (PerkinElmer).
Complementation of KO cells with cDNA UBA5 cDNA was obtained from Dharmacon (DNA Accession: BC009737, Clone ID: 3879061). To generate cDNA encoding catalytically inactive enzyme, a Cys250Arg mutation was introduced by PCR. Additionally, a C-terminal FLAG-tag was added to WT and CAT cDNA sequences. UFM1 was obtained from Dharmacon (cDNA Accession: BC005193, Clone ID: 3829206). N-terminal FLAG and C-terminal mutations (Gly83Ala or ∆C3 (deletion of GlySerCys)) were introduced by PCR. ZCCHC14 cDNA was obtained from Dharmacon (cDNA Accession: BC101478, Clone ID: 8068984). The N-terminus was extended using a Gblock (Integrated DNA Technologies) resembling the protein coding sequence for a longer isoform (1086 amino acids, ENST00000671377.1) to match the molecular weight of ZCCHC14 detected in WT Huh7.5.1 by immunoblot. PCR products were gel-purified and cloned into into EcoRV-cut pLenti CMV Puro DEST (w118-1) (Addgene #17452, gift from Eric Campeau & Paul Kaufman) using NEBuilder HiFi DNA Assembly Master Mix (New England BioLabs). Lentivirus was produced in HEK293FT and collected 48h post-transfection. KO cells were transduced with filtered, lentiviral containing supernatant under addition of polybrene and selected using 4 μg/ml puromycin for 3-4 days. For PAPD5 and PAPD7, pCI3 plasmids with WT or catalytic mutant cDNA sequences were kindly provided by V. Narry Kim and were described previously 36 . For transient complementation, plasmids were transfected into WT or DKO cells using TransIT-LT1 Transfection Reagent (Mirus Bio), and transfected cells were plated in 96-wells the next day for HAV infection. To generate stable cell lines, cDNA sequences were cloned into the PB-CMV-MCS-EF1α-Puro vector (PB510B-1, SBI System Biosciences) where the CMV promoter was replaced by a PGK promoter. Plasmids were co-transfected together with a plasmid expressing piggyBac transposase into PAPD5 KO cells, which were subsequently selected with puromycin for 5 days starting 3 days post-transfection. All primer sequences can be found in Supplementary Table 4 .
Immunoblotting
Cell were lysed using Laemmli SDS sample buffer containing 5% beta-mercaptoethanol and boiled for 10min. Lysates were separated by SDS-PAGE on pre-cast Bio-Rad 4-15% poly-acrylamide gels in Bio-Rad Mini-Protean electrophoresis system. Proteins were transferred onto PVDF membranes using Bio-Rad Trans-Blot Turbo transfer system. PVDF membranes were blocked with PBS buffer containing 0.1% Tween-20 and 5% non-fat milk. Blocked membranes were incubated with primary antibody diluted in blocking buffer and incubated overnight at 4C on a shaker. Primary antibodies were detected by incubating membranes with 1:4000 dilution of HRPconjugated (Southern Biotech) or 1:5000 dilution of IRDye-conjugated (LI-COR) secondary antimouse and anti-rabbit antibodies for 1 h at room temperature. Blots were visualized using a ChemiDoc MP Imaging System (Bio-Rad). The following primary antibodies (and their dilutions) were used in this study: p84 (Genetex, GTX70220) at 1:1000, GAPDH (SCBT, sc-32233) at 1:1000, FLAG M2 (Sigma, F1804) at 1:1000, UFM1 (Abcam, ab109305) at 1:1000, PAPD5 (Atlas Antibodies, HPA042968) at 1:1000 and ZCCHC14 (Bethyl, A303-096A) at 1:1000.
Replicon assay
The replicon plasmids pLuc-HAV/18f and pLuc-HAV/18f-3D pol GDDàGAA (replication-defective mutant) were kindly provided by Stanley Lemon and were described previously 60 . Plasmids were linearized using MluI-HF (New England BioLabs), RNA was generated using the MEGAscript T7 Kit (Invitrogen) and subsequently purified by lithium chloride precipitation. For electroporation, 1-2 million cells were washed three times in PBS, resuspended in 100μl SF Nucleofector solution (Lonza), mixed with 250ng replicon RNA per 80k cells, transferred to a 100 μl nucleocuvette and pulsed using the program FF-137 on an Amaxa 4D-Nucleofector X Unit (Lonza). Cells were then resuspended in equilibrated, antibiotic-free medium, distributed into 96-wells and lysed at different timepoints post-electroporation using 40μl Passive Lysis buffer (Promega). Luminescence was measured using Luciferase Assay System (Promega) on a white-walled luminescence plate with an EnVision plate reader (PerkinElmer).
Poly(A) tail length assay by polyacrylamide gel electrophoresis Cells were infected with HAV HM175/18f (MOI=10) and harvested 3 days post-infection using Trizol (Invitrogen). RNA was purified with Direct-zol RNA Microprep columns (Zymo Research). HAV poly(A) tails were analyzed using the Poly(A) Tail-Length Assay Kit (Thermo Scientific) according to the manufacturer's instructions. Briefly, 1μg total RNA per condition was used as input for G/I tailing reaction followed by reverse transcription. Next, RT products were amplified using different PCR primer combinations: i) HAV genome-specific (GS) forward and GS reverse primer, ii) GS forward and G/I reverse primer and iii) forward primer upstream of HAV poly(A) start site and G/I reverse primer. Finally, PCR products were analyzed using polyacrylamide gel electrophoresis on a 5% Mini-PROTEAN Tris/Boric Acid/EDTA (TBE) gel in TBE buffer (100V for 60min). Gel was stained with SYBR Gold (diluted 1:10000 in TBE buffer) for ~30min in the dark and imaged on a ChemiDoc MP Imaging System (Bio-Rad).
Poly(A) tail sequencing RNA was isolated from infected cells as described above. Ribosomal RNA (rRNA) was depleted from 1μg total RNA by addition of rRNA Removal Mix -Gold (Illumina) followed by incubation at 68C for 5min, addition of rRNA Removal Beads (Illumina), removal of supernatant while tubes are on a magnetic rack, and finally elution of rRNA-depleted RNA. Next, a 5´ adenylated, 3´ blocked oligodeoxynucleotide RNA linker (S1315S, New England BioLabs) was ligated to the 3' ends of RNAs by incubation with RNA ligase 2, truncated (New England BioLabs) for 3h at 22C. Ligation products were then reverse transcribed using a primer, which is reverse complement to the RNA linker, and Superscript IV (Invitrogen). Finally, HAV poly(A) tails were specifically amplified in a nested PCR, cloned into the pCRBlunt II-TOPO vector (Invitrogen) and Sanger sequenced (Quintarabio). Number of adenosines downstream of the HAV 3'UTR region and occurrence of non-adenosine nucleotides were counted.
Tapestation analysis of poly(A) tails of replicon RNA 10 6 cells were electroporated with in-vitro transcribed replicon RNA containing a 40bp long poly(A) tail as described above. For each timepoint, cells were washed with PBS, trypsined, pelleted and lysed using Trizol followed by RNA extraction with Direct-zol columns. Total RNA was G/I tailed, reverse transcribed and poly(A) tail region was amplified using forward primer upstream of HAV poly(A) start site and G/I reverse primer. Additionally, in-vitro transcribed replicon RNA was directly processed. Products were analyzed using a High Sensitivity D1000 ScreenTape System (Agilent).
Cell viability assay Huh7.5.1 cells were treated with different concentrations of RG7834 for 3 days and viability was measured using Cell Titer Glo (Promega) according to the manufacturer's instructions.
Culture and HAV infection of human liver organoids
Bi-potent stem cell organoids were generated as previously described 39, 61 . Briefly, we obtained liver tissue samples from the healthy resection margins of partial hepatectomies. Following tissue digest, the heterogeneous mixture of single cells was suspended in reduced growth factor BME2 (Basement Membrane Extract, Type 2, Trevigen). From this mixture, 50 µL drops containing 1,000 to 20,000 cells were seeded in 24-well suspension culture plates (GreinerBio). Drops were incubated at 37C for >20 min and solidified. After this, 500 µL of expansion media (EM) was added to each well. Expansion media is basal media (Advanced DMEM/F12 with 1% penicillin/streptomycin, 1% Glutamax, and 10 mM HEPES (all from ThermoFisher)) supplemented with 1% N2 (Gibco), 1% B27 (Gibco), 1 mM N-Acetylcysteine (Sigma-Aldrich), 10 nM [Leu 15 ]gastrin I human (Sigma-Aldrich), 10% (vol/vol) R-spondin1 conditioned media (generated as described in 39 ), and 10 mM Nicotinamide (Sigma-Aldrich). Expansion media additionally contains 50 ng/ml recombinant human EGF, 25 ng/ml recombinant human HGF, 100 ng/ml recombinant human FGF10, 10 µM Forskolin, and 5 µM A83-01 (all from Stem Cell Technologies). Expansion media was replaced every 3-4 days. Organoids in expansion media grew in culture for 4-6 months and needed to be routinely passaged with TRYPLE (Gibco). To induce differentiation to a hepatocyte-like fate, expansion media was supplemented with 25 ng/ml BMP7 (ProSpec) for 3-4 days. After this, media was changed to differentiation media (DM). Differentiation media is basal media supplemented with 1% N2, 1% B27, 1 mM N-acetylcysteine, 10 nM [Leu 15 ]-gastrin I human,
